1. Signaling Pathways
  2. Epigenetics
    TGF-beta/Smad
  3. PKC
  4. PKC Inhibitors

PKC Inhibitors

PKC

PKCα

PKCβ

PKCγ

PKCδ

PKCε

PKCη

PKCζ

PKCθ

PKCμ

PKCι

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PKC Inhibitors, Antagonists, Activators & Modulators
Product Name PKC PKCα PKCβ PKCγ PKCδ PKCε PKCη PKCζ PKCθ PKCμ PKCι Purity
Phorbol 12-myristate 13-acetate
PKC, EC50: 11.7 nM
                    ≥98.0%
Staurosporine
PKC, IC50: 6 nM
                    ≥98.0%
Go 6983  
PKCα, IC50: 7 nM
PKCβ, IC50: 7 nM
PKCγ, IC50: 6 nM
PKCδ, IC50: 10 nM
   
PKCζ, IC50: 60 nM
 
PKCμ, IC50: 20000 nM
  98.01%
Midostaurin  
cPKC-α, IC50: 22 nM
cPKC-β1, IC50: 30 nM
cPKC-β2, IC50: 31 nM
cPKC-γ, IC50: 24 nM
nPKC-δ, IC50: 33 nM
nPKC-ε, IC50: 1250 nM
nPKC-η, IC50: 160 nM
aPKC-ζ, IC50: 465000 nM
      ≥98.0%
Ruboxistaurin  
PKCα, IC50: 360 nM
PKC-βI, IC50: 4.7 nM
PKC-βII, IC50: 5.9 nM
PKCγ, IC50: 300 nM
PKCδ, IC50: 250 nM
PKCε, IC50: 600 nM
PKCη, IC50: 52 nM
        98.03%
CRT0066854 hydrochloride              
PKCζ, IC50: 639 nM
     
Mitoxantrone
PKC, IC50: 8.5 μM
                    ≥98.0%
Bisindolylmaleimide I
Bovine brain PKC, IC50: 10 nM
PKCα, IC50: 20 nM
PKCβII, IC50: 16 nM
PKCβI, IC50: 17 nM
PKCγ, IC50: 20 nM
              98.14%
Fasudil Hydrochloride
PKC, IC50: 12.30 μM
                    ≥95.0%
Sotrastaurin  
PKCα, Ki: 0.95 nM
PKCβI, Ki: 0.64 nM
 
PKCδ, Ki: 2.1 nM
PKCε, Ki: 3.2 nM
PKCη, Ki: 1.8 nM
 
PKCθ, Ki: 0.22 nM
    99.89%
Rottlerin  
PKCα, IC50: 30 μM (baculovirus-infected Sf9 insect cells)
PKCβ, IC50: 42 μM (baculovirus-infected Sf9 insect cells)
PKCγ, IC50: 40 μM (baculovirus-infected Sf9 insect cells)
PKCδ, IC50: 3 μM (Porcine spleen)
PKCε, IC50: 100 μM (baculovirus-infected Sf9 insect cells)
PKCη, IC50: 82 μM (baculovirus-infected Sf9 insect cells)
PKCζ, IC50: 100 μM (baculovirus-infected Sf9 insect cells)
      ≥95.0%
Enzastaurin  
PKCα, IC50: 39 nM
PKCβ, IC50: 6 nM
PKCγ, IC50: 83 nM
 
PKCε, IC50: 110 nM
          99.92%
Chelerythrine chloride
PKC, IC50: 660 nM
                    ≥98.0%
Afuresertib    
PKC-βI, IC50: 430 nM
     
PKCη, IC50: 210 nM
 
PKCθ, IC50: 510 nM
    99.86%
Ingenol Mebutate  
PKC-α, Ki: 0.3 nM
PKC-β, Ki: 0.105 nM
PKC-γ, Ki: 0.162 nM
PKC-δ, Ki: 0.376 nM
PKC-ε, Ki: 0.171 nM
          99.07%
Ro 31-8220 mesylate
Rat Brain PKC, IC50: 23 nM
PKC-α, IC50: 5 nM
PKC-βI, IC50: 24 nM
PKC-βII, IC50: 14 nM
PKC-γ, IC50: 27 nM
 
PKC-ε, IC50: 24 nM
          ≥98.0%
CGP60474
PKC
                    98.70%
D-erythro-Sphingosine
PKC
                    ≥98.0%
Mitoxantrone dihydrochloride
PKC, IC50: 8.5 μM
                    98.01%
Darovasertib  
PKCα, IC50: 1.9 nM
           
PKCθ, IC50: 0.4 nM
    99.68%
Verbascoside
PKC, IC50: 25 μM
                    99.83%
Ruboxistaurin hydrochloride  
PKCα, IC50: 360 nM
PKCβI, IC50: 4.7 nM
PKCβII, IC50: 5.9 nM
PKCγ, IC50: 300 nM
PKCδ, IC50: 250 nM
PKCε, IC50: 600 nM
PKCη, IC50: 52 nM
        99.84%
CMPD101  
PKCα, IC50: 8.1 μM
                  ≥98.0%
Daphnetin
PKC, IC50: 25.01 μM
                    99.21%
TPPB
PKC, Ki: 11.9 nM
                    99.81%
DCP-LA          
PKCε
          ≥98.0%
Afuresertib hydrochloride    
PKC-βI, IC50: 430 nM
     
PKCη, IC50: 210 nM
 
PKCθ, IC50: 510 nM
    98.02%
VTX-27  
PKCα, Ki: 356 nM
   
PKCδ, Ki: 16 nM
     
PKCθ, Ki: 0.08 nM
    99.64%
Delcasertib        
δPKC
            98.21%
BJE6-106  
PKCα, IC50: 50 μM
   
PKCδ, IC50: 0.05 μM
            98.17%
Ingenol
PKC, Ki: 30 μM
                    98.17%
Valrubicin
TPA-activated PKC, IC50: 0.85 μM
PDBu-activated PKC, IC50: 1.25 μM
                    99.95%
HA-100
PKC, IC50: 12 μM
PKC, Ki: 6.5 μM
                    99.77%
ζ-Stat              
aPKC-ζ, IC50: 5 μM
      ≥95.0%
Bisindolylmaleimide X hydrochloride
PKC
                    98.53%
KT5823
PKC, Ki: 4 μM
                    ≥99.0%
CRT0066854              
PKCζ, IC50: 639 nM
      ≥99.0%
Delcasertib hydrochloride        
δPKC
            98.11%
PKCβ inhibitor 1  
PKCα, IC50: 331 nM
human PKCβ1, IC50: 21 nM
human PKCβ2, IC50: 5 nM
                98.21%
PKC-theta inhibitor                
PKCθ, IC50: 12 nM
    99.75%
R 59-022
PKC
                    ≥99.0%
TCS 21311  
PKCα, IC50: 13 nM
           
PKCθ, IC50: 68 nM
    ≥98.0%
SB-218078
PKC, IC50: 1000 nM
                    ≥98.0%
DCPLA-ME          
PKCε
          ≥98.0%
ζ-Stat trisodium              
aPKC-ζ, IC50: 5 μM
     
Chelerythrine
PKC, IC50: 0.7 μM
                   
A-3 hydrochloride
PKC, Ki: 47 μM
                    99.67%
TAS-301
PKC
                    99.50%
Fasudil
PKC, IC50: 12.3 μM
                   
PKC-theta inhibitor 1  
PKCα, Ki: 1020 μM
   
PKCδ, Ki: 392 μM
     
PKCθ, Ki: 6 nM
   
C8-Ceramide
PKC
                    ≥98.0%
Epsilon-V1-2          
PKCε
         
N-Desmethyltamoxifen
PKC
                   
HBDDE  
PKCα, IC50: 43 μM
 
PKCγ, IC50: 50 μM
             
PKC β pseudosubstrate    
PKC-β
               
PS315            
PKCη, IC50: 30 μM
PKCζ, IC50: 10 μM
     
[Ala113]MBP(104-118)
PKC, IC50: 28-62 μM
                   
Aurothiomalate sodium                    
PKCι
AS2521780  
PKCα, IC50: 160 nM
   
PKCδ, IC50: 160 nM
PKCε, IC50: 18 nM
   
PKCθ, IC50: 0.48 nM
   
Bisindolylmaleimide IV
PKC, IC50: 0.1-0.55 μM
                   
Ro 32-0432 hydrochloride  
PKCα, IC50: 9.3 nM
PKC-βI, IC50: 28 nM
PKC-βII, IC50: 30 nM
PKCγ, IC50: 36.5 nM
 
PKCε, IC50: 108.3 nM
         
[Ala107]MBP(104-118)
PKC, IC50: 46-145 μM
                   
PKC β pseudosubstrate TFA    
PKCβ
               
[Ala113]MBP(104-118) TFA
PKC, IC50: 28-62 μM
                   
Bisindolylmaleimide VIII acetate
Rat Brain PKC, IC50: 158 nM
PKC-α, IC50: 53 nM
PKC-βI, IC50: 195 nM
PKC-βII, IC50: 163 nM
PKC-γ, IC50: 213 nM
 
PKC-ε, IC50: 175 nM
         
[Ala107]MBP(104-118) TFA
PKC, IC50: 46-145 μM